Advertisement

Topics

Bavarian Nordic A/S: Bavarian Nordic Announces Closing of Transaction with Janssen Pharmaceuticals, Inc. and Issue of Shares to Johnson & Johnson Innovation - JJDC, Inc.

15:41 EDT 21 Aug 2017 | FinanzNachrichten

COPENHAGEN, Denmark, August 21, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced the closing of the transaction with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceut...

Original Article: Bavarian Nordic A/S: Bavarian Nordic Announces Closing of Transaction with Janssen Pharmaceuticals, Inc. and Issue of Shares to Johnson & Johnson Innovation - JJDC, Inc.

NEXT ARTICLE

More From BioPortfolio on "Bavarian Nordic A/S: Bavarian Nordic Announces Closing of Transaction with Janssen Pharmaceuticals, Inc. and Issue of Shares to Johnson & Johnson Innovation - JJDC, Inc."

Advertisement
Quick Search
Advertisement
Advertisement